Nevertheless, beyond glycemic and blood pressure control, other potential mechanisms for preserving renal function with a GLP-1R agonist treatment include anti-inflammatory actions, reduced fibrosis, and reduced glomerular sclerosis [15]. The gene discussed is GLP1R; the disease is glomerulosclerosis.